Child psychiatric disorder and relative age within school year: cross sectional survey of large population sample

被引:99
作者
Goodman, R [1 ]
Gledhill, J
Ford, T
机构
[1] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England
[2] Imperial Coll Sch Med St Marys, London W2 1PG, England
来源
BMJ-BRITISH MEDICAL JOURNAL | 2003年 / 327卷 / 7413期
关键词
D O I
10.1136/bmj.327.7413.472
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To test the hypothesis that younger children in, a school year are at greater risk of emotional and behavioural problems. Design Cross sectional survey. Setting Community sample from England, Scotland, and Wales. Participants 10438 British 5-15 year olds. Main outcome measures Total symptom scores on psychopathology questionnaires completed by parents, teachers, and 11-15 year olds; psychiatric diagnoses based on a clinical review of detailed interview data. Results Younger children in a school year were significantly more likely to have higher symptom scores and psychiatric disorder. The adjusted regression coefficients for relative age were 0.51 (95% confidence interval 0.36 to 0.65, P<0.0001) according to teacher report and 0.35 (0.23 to 0.47, P=0.0001) for parental report. The adjusted odds ratio for psychiatric diagnoses for decreasing relative age was 1.14 (1.03 to 1.25, P=0.009). The effect was evident across different measures, raters, and age bands. Cross national comparisons supported a "relative age" explanation based on the disadvantages of immaturity rather than a "season of birth" explanation based on seasonal variation in biological risk. Conclusions The younger children in a school year are at slightly greater psychiatric risk than older children. Increased awareness by teachers of the relative age of their pupils and a more flexible approach to children's progression through school might reduce the number of children with impairing psychiatric disorders in the general population.
引用
收藏
页码:472 / 475
页数:18
相关论文
共 143 条
[1]  
ABDULKADYROV KM, 1993, TERAPEVT ARKH, V65, P70
[2]  
Abildgaard N, 1998, EUR J HAEMATOL, V61, P128
[3]  
ADAMI S, 1989, RECENT RES CANCER, V116, pS67
[4]   Safety and efficacy of bisphosphonates beyond 24 months in cancer patients [J].
Ali, SM ;
Esteva, FJ ;
Hortobagyi, G ;
Harvey, H ;
Seaman, J ;
Knight, R ;
Costa, L ;
Lipton, A .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (14) :3434-3437
[5]  
[Anonymous], 1994, The ICD-10 classification of mental and Behavioural disorders: Conversion tables between ICD-8, ICD-9 and ICD-10
[6]  
[Anonymous], 2001, COCHRANE REV HDB
[7]   The effect of two different doses of oral clodronate on pain in patients with bone metastases [J].
Arican, A ;
Içli, F ;
Akbulut, H ;
Çakir, M ;
Sencan, O ;
Samur, M ;
Açikgöz, N ;
Demirkazik, A .
MEDICAL ONCOLOGY, 1999, 16 (03) :204-210
[8]   EFFECTS OF A NEW AMINODIPHOSPHONATE (AMINOHYDROXYBUTYLIDENE DIPHOSPHONATE) IN PATIENTS WITH OSTEOLYTIC LESIONS FROM METASTASES AND MYELOMATOSIS - COMPARISON WITH DICHLOROMETHYLENE DIPHOSPHONATE [J].
ATTARDOPARRINELLO, G ;
MERLINI, G ;
PAVESI, F ;
CREMA, F ;
FIORENTINI, ML ;
ASCARI, E .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (09) :1629-1633
[9]  
AUSGABE A, 1997, UROLOGE, V36, P568
[10]  
Ausili-Cefaro Giampiero, 1999, Rays (Rome), V24, P49